This study compared auditory behavioral and physiologic measures in normal control subjects and subjects prescribed with a selective serotonin reuptake inhibitor (SSRI) who were yet to take the drug and those currently taking an SSRI. Test measures used were pure tone averages (PTA), acoustic reflex thresholds, uncomfortable loudness levels (UCL), otoacoustic emissions, masking level difference, temporal integration, amplitude resolution, and Beck Depression Inventory-II (BDI-II) scores. Results indicated that there was a significant difference in the amplitude resolution of the unmedicated group when compared to the medicated and the control group. There was also a significant positive correlation between dynamic range (difference between UCL and PTA) and amplitude resolution. The BDI-II revealed a significant difference between the scores of the unmedicated and the control group as well as the medicated and the control group. Although other test measures indicated differences between the groups, the differences were not statistically significant.

Das serotonerge System besitzt sowohl bei Invertebraten als auch bei Vertebraten eine große Bedeutung für die Kontrolle und Modulation vieler physiologischer Prozesse und Verhaltensleistungen. Bei der Honigbiene Apis mellifera spielt Serotonin (5-Hydroxytryptamin, 5-HT) eine wichtige Rolle bei der Arbeitsteilung und dem Lernen. Die 5-HT-Rezeptoren, die überwiegend zur Familie der G-Protein gekoppelten Rezeptoren (GPCRs) gehören, besitzen eine Schlüsselstellung für das Verständnis der molekularen Mechanismen der serotonergen Signalweiterleitung. Ziel dieser Arbeit war es, 5-HT-Rezeptoren der Honigbiene zu charakterisieren. Dazu zählt die Identifizierung der molekularen Struktur, die Ermittlung der intrazellulären Signalwege, die Erstellung von pharmakologischen Profilen, die Ermittlung der Expressionsmuster und die Ermittlung der physiologischen Funktionen der Rezeptoren. Mit Hilfe der Informationen aus dem Honey Bee Genome Project, konnten drei RezeptorcDNAs kloniert werden. Vergleiche der abgeleiteten Aminosäuresequenzen mit den Aminosäuresequenzen bereits charakterisierter Rezeptoren legten nahe, dass es sich dabei um einen 5-HT1- (Am5-HT1) und zwei 5-HT2-Rezeptoren (Am5-HT2α und Am5-HT2β) handelt. Die strukturelle Analyse der abgeleiteten Aminosäuresequenz dieser Rezeptoren postuliert das Vorhandensein der charakteristischen heptahelikalen Architektur von GPCRs und zeigt starkkonservierte Motive, die bedeutend für die Ligandenbindung, die Rezeptoraktivierung und die Kopplung an G-Proteine sind. Für die beiden 5 HT2-Rezeptoren konnte zudem alternatives Spleißen nachgewiesen werden. Mit den cDNAs des Am5-HT1- und des Am5-HT2α-Rezeptors wurden HEK293-Zellen stabil transfiziert und anschließend die Rezeptoren funktionell und pharmakologisch analysiert. Am5-HT1 hemmt bei Aktivierung abhängig von der 5-HT-Konzentration die cAMPProduktion.Die Substanzen 5-Methoxytryptamin (5-MT) und 5-Carboxamidotryptamin konnten als Agonisten identifiziert werden. Methiothepin dagegen blockiert die 5-HTWirkung vollständig. Prazosin und WAY100635 stellen partielle Antagonisten des Am5-HT1-Rezeptors dar. Der Am5-HT2_-Rezeptor stimuliert bei Aktivierung die Synthese des sekundären Botenstoffs Inositoltrisphosphat, was wiederum zu einer messbaren Erhöhung der intrazellulären Ca2+-Konzentration führt. 5-MT und 8-OH-DPAT zeigen eine deutliche agonistische Wirkung auf Am5-HT2α. Dagegen besitzen Clozapin, Methiothepin, Mianserin und Cyproheptadin die Fähigkeit, die 5-HT-Wirkung um 51-64 % zu vermindern. Die bereits erwähnte alternative Spleißvariante von Am5-HT2α wurde ebenfalls in HEK293-Zellen exprimiert und analysiert, scheint jedoch eigenständig nicht funktionell zu sein. Gegen die dritte cytoplasmatische Schleife (CPL3) wurde ein polyklonales Antiserum generiert. Dieses erkennt in Western-Blot-Analysen ein Protein mit einer Masse von ca. 50 kDa. Durch immunhistochemische Analysen am Bienengehirn wurde die Verteilung des Rezeptors genauer untersucht. Dabei zeigten die optischen Neuropile, besonders die Lamina und die Ocellarnerven, stets eine starke Markierung. Außerdem wird der Rezeptor in den α- und β-Loben sowie der Lippe, dem Basalring und dem Pedunculus der Pilzkörper exprimiert. Doppelmarkierungen zeigen stets eine enge Nachbarschaft von serotonergen Fasern und dem Am5-HT1-Rezeptor. Weiterhin konnte gezeigt werden, dass der Am5-HT1-Rezeptor sehr wahrscheinlich an der Regulation des phototaktischen Verhalten der Honigbiene beteiligt ist. Verfütterung von 5-HT hat eine deutlich negative Wirkung auf das phototaktischen Verhalten. Diese kann durch den Am5-HT1-Rezeptor-Agonisten 5-CT imitiert werden. Schließlich konnte gezeigt werden, dass der Am5-HT1-Antagonist Prazosin die 5-HT-Wirkung deutlich vermindern kann. / The serotonergic system plays an important role in the control and modulation of many physiological and behavioral processes in both vertebrates and invertebrates. In the honeybee Apis mellifera, serotonin (5-hydroxytryptamine, 5-HT) has been implicated in the control and regulation of division of labor as well as learning and memory. A key role in understanding the serotonergic system plays the molecular and functional characterization of 5-HT receptor subtypes. In most cases, serotonin receptors represent G protein-coupled receptors (GPCRs). This work describes the characterization of honeybee serotonin receptors. This comprises the identification of their molecular structure, intracellular second messenger pathways, pharmacological properties, expression profiles and functions. By screening the honeybee genome, we found three candidate genes encoding for putative serotonin receptors. The cDNAs of these genes were cloned and the deduced amino acid sequences were analysed. The sequence information was used to isolate the cDNAs encoding for these three receptors. Comparison of the deduced amino acid sequences with sequences of other known receptors suggests that one receptor belongs to the 5-HT1 (Am5-HT1) and the other two receptors to the 5-HT2 receptor class (Am5-HT2α and Am5-HT2β). Major characteristics common to all GPCRs (e.g. the heptahelical architecture) were confirmed by structural analyses of the deduced amino acid sequences. Furthermore, truncated receptor transcripts representing alternative splice variants of both 5-HT2 receptors could be detected. HEK293 cells were stably transfected with the cDNAs of Am5-HT1 or Am5-HT2_ and functionally and pharmacologically analysed. The activation of Am5-HT1 by 5-HT results in the dose dependent attenuation of adenylyl cyclase activity. 5-methoxytryptamine (5-MT) and 5-carboxamidotryptamine are able to imitate the 5-HT effect. In contrast, methiothepin is able to block the entire 5-HT effect, whereas prazosine and WAY100635 block the 5-HT effect only partially. The Am5-HT2α receptor stimulates the synthesis of the second messenger inositol trisphosphate which in turn mediates an increase in the intracellular Ca2+. The substances 5-MT and 8-OH-DPAT were identified as agonists of the Am5-HT2α receptor. In contrast, clozapine, methiothepine, mianserine, and cyproheptadine show strong antagonistic actions. A truncated alternative splice variant of the Am5-HT2α-receptor was also analysed but didn’t show any functional coupling by itself. An antiserum was raised against the third cytoplasmic loop (CPL3) of the Am5-HT1 receptor. This antiserum detects a protein with a molecular mass of 50 kDa in western blot analyses. The expression of the Am5-HT1 receptor was studied in detail using immunohistochemistry. Strong Am5-HT1-like immunofluorescence was observed in the ocellar nerve, in the three optic ganglia and in the α- and β-lobes, the pedunculi, the lip and the basal ring of the mushroom bodies. Furthermore, co-labeling with an antibody against 5-HT showed that this receptor is expressed in close vicinity to serotonergic neurons. Finally, behavioral experiments suggest a possible role of the Am5-HT1 receptor in phototactic behavior. Feeding of 5-HT to worker honeybees results in a decrease of phototactic behavior. This 5-HT action could be mimiced by feeding of the Am5-HT1 agonist 5-CT. In contrast, the Am5-HT1 antagonist prazosine prevents the 5-HT-induced decrease in phototaxis.

Bibliography: leaves 118-161 / 161 [46] leaves : ill ; 30 cm. / Title page, contents and abstract only. The complete thesis in print form is available from the University Library. / Thesis (Ph.D.)--University of Adelaide, Dept. of Physiology, 1984

Diss. (sammanfattning) Stockholm : Karol. inst., 2005. / Härtill 5 uppsatser.

No description available.

Alzheimer´s disease (AD) is an age-related, irreversible and progressive neurodegenerative pathology that deteriorates cognitive function including learning and memory. AD is characterised neuropathologically by the presence of neuritic plaques (Aβ), neurofibrillary tangles (NFTs), synaptic loss and neuronal death. AD affects specific brain regions involved in mnestic function such as the neocortex and the hippocampus. The dorsal (DR) and the median raphe (MR) nuclei give rise to serotonergic (5-HT) projections that innervate multiple brain regions including the cortex and the hippocampus, playing an important role in learning and memory processes. For a long time the degeneration of cholinergic (ACh) system was considered as the main neurochemical changes in AD brains, however, more recent studies highlight the involvement of other neurotransmitter systems including 5-HT. This thesis entitled “Altered serotonergic neurotransmission as a main player in the pathophysiology of Alzheimer’s disease: structural and ultrastructural studies in a triple transgenic mouse model of the disease” demonstrates that there exist specific alterations in the serotonergic projections of the hippocampus during the progression of AD using the triple transgenic (3xTg-AD) mouse model of the disease, which closely resemble human AD. Mr. Harun N. Noristani is submitting this thesis to the University of Manchester for the degree of PhD in the Faculty of Life Science. The results obtained in this thesis show for the first time a biphasic increase in serotonergic fibre sprouting in the 3xTg-AD mouse model of AD that occurs in parallel with evident intraneuronal/extracellular Aβ deposition in the hippocampus (Chapter 3). In addition, serotonergic fibre sprouting correlated with reduced perforated synapses in the hippocampus, suggesting a structural remodeling process to maintain hippocampal connectivity (Chapter 4). Increased 5-HT neurotransmission (via high dietary intake of tryptophan, 5-HT precursor) reduced intraneuronal Aβ accumulation in the hippocampus, suggesting a direct role of 5-HT neurotransmission in modifying AD neuropathology (Chapter 5). Given the protective role of increased 5-HT neurotransmission, treatment with 5-HT enhancing drugs may be beneficial in reducing the underlying pathology as well as improving the behavioural and cognitive abnormalities associated with AD. Nevertheless, the role of specific 5-HT receptors responsible for such neuro-protective effect of 5-HT in AD awaits further research.

Recently, it has been discovered that serotonin (5-HT) receptors exist as subtypes in the mammalian brain. At least two major subtypes that differ in their distribution, and affinity for serotonergic drugs, have now been described. These receptors have been labeled 5-HT₁, and 5-HT₂ receptors. The purpose of this thesis is to determine what roles the 5-HT₁, and 5-HT₂ receptors might play in the modulation of sexual behaviour in the female rat. The administration of the 5-HT₂ receptor antagonist pirenperone inhibited sexual receptivity in adult, ovariectomized Sprague Dawley rats that had been primed either chronically with estradiol benzoate (EB), or acutely with EB plus varying doses of progesterone (P). An inhibition occurred at peripherally administered doses of 50, 100 and 150, but not 25 µg/kg of pirenperone. Pirenperone also inhibited receptivity when administered intraventricularly at a dose of 15 µg/kg, however this dose of pirenperone was ineffective when administered peripherally. Increasing the dose of P did not attenuate the inhibitory effect of pirenperone. The 5-HT₂ antagonists ketanserin (2.5 mg/kg) and spiperone (250 µg/kg) also inhibited receptivity in females that had been primed with EB plus P. The inhibitory effect of pirenperone was attenuated by the 5-HT₂ agonist quipazine , however the 5-HT precursor 5-hydroxytryptophan (5-HTP) (20 mg/kg), and the 5-HT₁, agonists 5-methoxy-N,N-dimethytryptamine (5MeODMT) (200 µg/kg) and tryptamine (2 mg/kg) did not attenuate the effect of pirenperone. Quipazine, 5-HTP, and 5MeODMT did not effect receptivity in females that had been primed with EB plus P, however tryptamine inhibited receptivity. Whereas the nonselective 5-HT antagonist methysergide (3 mg/kg) failed to have an effect on receptivity in females that had been primed with EB, methysergide coadministered with quipazine facilitated receptivity. Pirenperone also inhibited proceptivity in females that had been primed with EB plus P. Although quipazine did not attenuate the inhibitory effect of pirenperone upon proceptivity, quipazine alone facilitated proceptivity in females that had been primed either with EB, or with EB and P. Methysergide did not effect proceptivity, and 5-HTP, 5MeODMT, and tryptamine were also ineffective with regards to proceptivity. The results of the present series of experiments are not entirely consistent with Meyerson's widely held theory of serotonergic inhibition , rather they suggest a dual role for 5-HT in female sexual behaviour. Therefore, a new theory regarding the role of 5-HT in sexual behaviour is proposed. Specifically, it is proposed that inhibitory effects of 5-HT are mediated by activity at 5-HT₁, receptors, whereas facilitatory effects are mediated by activity at 5-HT₂ receptors. / Arts, Faculty of / Psychology, Department of / Graduate

abstract: Serotonin 1B receptor (5-HT1BR) agonists enhance cocaine intake in rats during daily self-administration (SA) sessions, yet decrease cocaine intake after prolonged abstinence. The goal of my dissertation was to examine if 5-HT1BRs are suitable targets for treatment development to attenuate psychostimulant intake. I first investigated if 5-HT1BR agonist effects that had been observed with cocaine generalize across psychostimulants, i.e., methamphetamine. Rats trained to self-administer methamphetamine received either CP 94,253 or the clinically-available but less selective 5-HT1D/1BR agonist, zolmitriptan, prior to tests for effects on SA both before and after a 21-day abstinence period. I found that CP 94,253 and zolmitriptan decreased the reinforcing and incentive motivational effects of methamphetamine, regardless of abstinence, unlike the pre-abstinence increase in cocaine SA observed previously with 5-HT1BR agonists. The attenuating effects of CP 94,253 on methamphetamine were antagonized in a 5-HT1BR-mediated manner. Subsequently, I investigated the efficacy and mechanism involved in effects of zolmitriptan on cocaine SA in male and female rats. Rats trained to self-administer cocaine received zolmitriptan prior to tests for effects on SA before a 21-day abstinence period. I found that zolmitriptan decreased cocaine intake in both sexes regardless of abstinence and without altering sucrose intake. I further demonstrated that the zolmitriptan effects on cocaine SA were mediated by both 5-HT1BRs and 5-HT1DRs. Finally, I examined if the abstinence-induced decrease in cocaine intake observed with the selective 5-HT1BR agonist, CP 94,253, persists during relapse after abstinence or reverts to enhancing cocaine intake, similar to effects observed without an abstinence period. Rats trained to self-administer cocaine resumed daily cocaine SA sessions after the forced abstinence period to investigate the effects of CP 94,253 on cocaine relapse. I found that CP 94,253 attenuated cocaine intake in relapse tests, suggesting that the abstinence-dependent attenuation of CP 94,253 on cocaine SA remains even after resumption of daily cocaine intake. The findings suggest that 5-HT1BR agonists like CP 94,253 and zolmitriptan have clinical potential as treatments for psychostimulant use disorders. / Dissertation/Thesis / Doctoral Dissertation Neuroscience 2020

The role of operant behavior in the metabolism of brain 5-hydroxytryptamine (5-HT) turnover was investigated. Two and one-half hours following the administration of 150 mg/kg of para-chlorophenylalanine (PCPA), a specific inhibitor of tryptophan hydroxylase, levels of 5-HT were compared in sedentary and performing rats. Whole brain levels of serotonin were reduced in both responding and sedentary animals; however, differences between these groups were not statistically significant. The drug induced decrease in 5-HT levels was accompanied by a significant decrease in session responding. The degree of suppressed responding could be correlated with the level of 5-HT following PCPA, suggesting that the metabolism of serotonin is in part modulated by the rate of responding as maintained by the operant schedule.

No description available.